As of now, there’s no therapy approved by the United States Food and Drug Administration for asymptomatic people at risk of Alzheimer’s disease. But blood tests that can spot biomarkers linked to the ...

For much of the past century, Alzheimer's disease has been one of medicine's most daunting frontiers—biologically complex, ...

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." Alzheimer’s disease, the most common form of dementia affecting more than three million Americans a year, ...

With the approval of anti-amyloid monoclonal antibodies to treat early-stage Alzheimer’s disease (AD), the need for accurate and early diagnosis is crucial. Blood-based biomarkers offer a promising ...

Earlier this month, the FDA approved another biomarker to help millions of patients and families affected by Alzheimer’s disease: a blood test that detects amyloid plaques, a hallmark of the disease.

Obesity accelerates the rise of Alzheimer’s-related blood biomarkers far more rapidly than previously recognized. Long-term imaging and plasma data show that obese individuals experience much faster ...

TORONTO — An expert panel convened by the Alzheimer’s Association has released the first clinical guidelines to help clinicians choose the most appropriate blood-based biomarker (BBM) test to aid in ...

New test elevates the performance standard for blood biomarker tests intended for detecting amyloid pathology in individuals with cognitive impairment BILLERICA, Mass.--(BUSINESS WIRE)--Lucent ...

Researchers have conducted the first study evaluating the impact of obesity on Alzheimer's disease blood biomarkers (BBMs). BBM values increased up to 95% faster in individuals with obesity than in ...

HEAVYWEIGHT WELLNESS COMPANIES in the $77.6 billion global biomarker market are promising to enhance your healthspan through huge batches of screenings. Some services, like InsideTracker, test ...